Protagonist Therapeutics Company Insiders

Protagonist Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of 0.1996 % which means that it generated a profit of $0.1996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4097 %, meaning that it created $0.4097 on every $100 dollars invested by stockholders. Protagonist Therapeutics' management efficiency ratios could be used to measure how well Protagonist Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.23 in 2024. Return On Capital Employed is likely to drop to -0.29 in 2024. Total Assets is likely to drop to about 204.1 M in 2024. Net Tangible Assets is likely to drop to about 141.3 M in 2024Common Stock Shares Outstanding is likely to drop to about 29.8 M in 2024. Net Loss is likely to rise to about (108.9 M) in 2024

Protagonist Therapeutics Workforce Comparison

Protagonist Therapeutics Profit Margins

The company has Profit Margin (PM) of 0.53 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (8.87) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $8.87.

Protagonist Therapeutics Insider Trading History

Protagonist Therapeutics Notable Stakeholders

The success or failure of an entity such as Protagonist Therapeutics often depends on how effective the management is. Protagonist Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Protagonist management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Protagonist management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Protagonist Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Protagonist Therapeutics. Check Protagonist Therapeutics' Beneish M Score to see the likelihood of Protagonist Therapeutics' management manipulating its earnings.

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.